FR2910M - Nouvelle forme injectable d'ortho-hydroxyquinoléine sulfonate de phényl-1 diméthyl-2,3 diméthylamino-4 pyrazolone-5 utile dans la thérapie anti-grippale et antirhumastimale. - Google Patents

Nouvelle forme injectable d'ortho-hydroxyquinoléine sulfonate de phényl-1 diméthyl-2,3 diméthylamino-4 pyrazolone-5 utile dans la thérapie anti-grippale et antirhumastimale.

Info

Publication number
FR2910M
FR2910M FR940455A FR940455A FR2910M FR 2910 M FR2910 M FR 2910M FR 940455 A FR940455 A FR 940455A FR 940455 A FR940455 A FR 940455A FR 2910 M FR2910 M FR 2910M
Authority
FR
France
Prior art keywords
antirhumastimal
pyrazolone
influenza
ortho
dimethylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR940455A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Causyth Chim Farm
Laboratorio Chimico Farmaceutico Causyth SpA
Original Assignee
Causyth Chim Farm
Laboratorio Chimico Farmaceutico Causyth SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Causyth Chim Farm, Laboratorio Chimico Farmaceutico Causyth SpA filed Critical Causyth Chim Farm
Application granted granted Critical
Publication of FR2910M publication Critical patent/FR2910M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR940455A 1967-05-18 1963-07-05 Nouvelle forme injectable d'ortho-hydroxyquinoléine sulfonate de phényl-1 diméthyl-2,3 diméthylamino-4 pyrazolone-5 utile dans la thérapie anti-grippale et antirhumastimale. Expired FR2910M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH701567A CH487897A (de) 1967-05-18 1967-05-18 Verfahren zur Herstellung eines wasserlöslichen Komplexes des 8-Hydroxy-chinolin-(-sulfonates von 1,5-Dimethyl-4-dimethyl-amino-2-phenyl-3-isopyrazolon

Publications (1)

Publication Number Publication Date
FR2910M true FR2910M (fr) 1964-11-09

Family

ID=4318592

Family Applications (1)

Application Number Title Priority Date Filing Date
FR940455A Expired FR2910M (fr) 1967-05-18 1963-07-05 Nouvelle forme injectable d'ortho-hydroxyquinoléine sulfonate de phényl-1 diméthyl-2,3 diméthylamino-4 pyrazolone-5 utile dans la thérapie anti-grippale et antirhumastimale.

Country Status (4)

Country Link
BE (1) BE629650A (enrdf_load_stackoverflow)
CH (1) CH487897A (enrdf_load_stackoverflow)
FR (1) FR2910M (enrdf_load_stackoverflow)
GB (1) GB1072359A (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093999A3 (en) * 1982-05-08 1985-05-15 Godecke Aktiengesellschaft Pharmaceutical formulations of oxicam derivatives, and process for preparing them

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3437232A1 (de) * 1984-10-10 1986-04-17 Mack Chem Pharm Stabilisierte injektionsloesungen von piroxicam
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093999A3 (en) * 1982-05-08 1985-05-15 Godecke Aktiengesellschaft Pharmaceutical formulations of oxicam derivatives, and process for preparing them

Also Published As

Publication number Publication date
CH487897A (de) 1970-03-31
GB1072359A (en) 1967-06-14
BE629650A (enrdf_load_stackoverflow) 1900-01-01

Similar Documents

Publication Publication Date Title
IT941365B (it) Traliccio di ossatura
HU174670B (hu) Sposob razdelenija i/ili podschjota odnikh ehlementov vehhestva s pochti pol'nost'ju ravnomernym razmerom granul
BR7108466D0 (pt) Anestesicos locais e acilxilididas e processo de sua preparacao
FR1400747A (fr) Boulon d'ancrage à expansion
FR1501679A (fr) Boulon d'ancrage
FR3222M (fr) Médicament psychotrope antidépressif.
BR7307461D0 (pt) Rido-(4-3-d)-pirimidin-4-(3h)-onas 2 substituidas, e proceprocesso para preparar pirido-(2-3-d), piripo-(3-4-d) e pisso para preparar amino-nicotino-nitrilas
FR3518M (fr) Nouvelles formulations d'antibiotiques de la série de la tétracycline.
FR2910M (fr) Nouvelle forme injectable d'ortho-hydroxyquinoléine sulfonate de phényl-1 diméthyl-2,3 diméthylamino-4 pyrazolone-5 utile dans la thérapie anti-grippale et antirhumastimale.
BE775607A (fr) Emulsions aqueuses d'alcoylhydrogenopolysiloxanes de haute stabilite
BR6676881D0 (pt) Processo de preparacao de 4-metil-carbamato 2,3-di-hidro-2 2-dimetil-7-benzofuranilico e de intermediarios reacionais do mesmo
FR1492765A (fr) Production d'alkyl-3, 4-dihydroxyphénylalanines optiquement actives
FI44913C (fi) Menetelmä uusien substituoitujen fenyyliamino-1,3-diatsasyklopenteenien-(2) valmistamiseksi, joilla on verenpainetta alentava ja rauhoittava vaikutus
FI43881C (fi) Menetelmä uusien, farmakologisesti arvokkaiden 1-aryylioksi-2-hydroksi-isopropyyliamino-propaanien ja niiden suolojen valmistamiseksi
BR6574917D0 (pt) Novos benzisotiazois substituidos e processo para preparar os mesmos
BR6683481D0 (pt) Compostos farmacologicamente ativos e o processo da sua obtencao
BE764011A (fr) Agents antidepresseurs
SE394675B (sv) 2,5-dimetylfuran-3-karbonsyracyklohexylamid med fungicid verkan
AT276399B (de) Verfahren zur Herstellung von 2,4,5-Trichlorpyrimidin und 2,4,5,6-Tetrachlorpyrimidin
NL148058B (nl) Isoxazoolderivaten met anti-pyretische, analgetische, anti-tussieve en/of anti-inflammatoire werking.
BR6572749D0 (pt) Processo para preparar l-metil-3-(2-(5-nitro-2-furil)vinil2-1 2 4-triazolin-5-ona e intermediario do mesmo
FR3805M (fr) Nouvelle &delta<4>-7α-méthyl-17β-hydroxy-19-nor-androstene-3-one utilisable en thérapie.
AT319246B (de) Vzh von neuen 1,2,3,4-tetrahydroisochinolinderivaten
BR7100607D0 (pt) Processo de copolimerizacao de acrilonitrila e de monomeros sulfonicos
FR3143M (fr) Amides d'acides β-phényl-β-oxypropionique et β-acéto-amido-β-phénylpropionique.